{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:03:07Z","timestamp":1783702987053,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12891-017-1547-8","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T16:38:59Z","timestamp":1495125539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Immunogenicity and immunomodulatory effects of the human chondrocytes, hChonJ"],"prefix":"10.1186","volume":"18","author":[{"given":"Chae-Lyul","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Ho","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heonsik","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bumsup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,18]]},"reference":[{"key":"1547_CR1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1517\/14712598.2015.1009886","volume":"15","author":"RK Elmallah","year":"2015","unstructured":"Elmallah RK, Cherian JJ, Jauregui JJ, et al. Genetically modified chondrocytes expressing TGF-\u03b21: a revolutionary treatment for articular cartilage damage? Expert Opin Biol Ther. 2015;15:455.","journal-title":"Expert Opin Biol Ther"},{"key":"1547_CR2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrrheum.2015.28","volume":"11","author":"CH Evans","year":"2015","unstructured":"Evans CH, Huard J. Gene therapy approaches to regenerating the musculoskeletal system. Nat Rev Rheumatol. 2015;11:234.","journal-title":"Nat Rev Rheumatol"},{"key":"1547_CR3","doi-asserted-by":"crossref","unstructured":"Cucchiarini M and Madry H. Gene Therapy for Human Osteoarthritis. Osteoarthritis - Diagnosis, Treatment and Surgery, Prof. Qian Chen (Ed.), 2012, ISBN: 978-953-51-0168-0","DOI":"10.5772\/26150"},{"key":"1547_CR4","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1089\/ten.2005.11.1516","volume":"11","author":"SU Song","year":"2005","unstructured":"Song SU, Cha YD, Han JU, et al. Hyaline cartilage regeneration using mixed human chondrocytes and transforming growth factor-beta1-producing chondrocytes. Tissue Eng. 2005;11:1516.","journal-title":"Tissue Eng"},{"key":"1547_CR5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/14653240903470639","volume":"12","author":"MJ Noh","year":"2010","unstructured":"Noh MJ, Copeland RO, Yi Y, et al. Pre-clinical studies of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 (TG-C). Cytotherapy. 2010;12:384.","journal-title":"Cytotherapy"},{"key":"1547_CR6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/ten.2005.11.310","volume":"11","author":"DK Lee","year":"2005","unstructured":"Lee DK, Choi KB, Oh IS, et al. Continuous transforming growth factor beta1 secretion by cell-mediated gene therapy maintains chondrocyte redifferentiation. Tissue Eng. 2005;11:310.","journal-title":"Tissue Eng"},{"key":"1547_CR7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/14653249.2011.629645","volume":"14","author":"CW Ha","year":"2012","unstructured":"Ha CW, Noh MJ, Choi KB, Lee KH. Initial phase I safety of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 in degenerative arthritis patients. Cytotherapy. 2012;14:247.","journal-title":"Cytotherapy"},{"key":"1547_CR8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/humc.2014.145","volume":"26","author":"CW Ha","year":"2015","unstructured":"Ha CW, Cho JJ, Elmallah RK, et al. A multicenter, single-blind, phase IIa clinical trial to evaluate the efficacy and safety of a cell mediated gene therapy in degenerative knee arthritis patients. Hum Gene Ther Clin Dev. 2015;26:125.","journal-title":"Hum Gene Ther Clin Dev"},{"key":"1547_CR9","first-page":"924","volume":"97","author":"MC Lee","year":"2015","unstructured":"Lee MC, Ha CW, Elmallah RD, et al. A placebo-controlled randomised trial to assess the effect of TGF-\u00df1-expressing chondrocytes in patients with arthritis of the knee. Bone Joint J. 2015;97:924.","journal-title":"Bone Joint J"},{"issue":"12","key":"1547_CR10","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.joca.2015.06.019","volume":"23","author":"JJ Cherian","year":"2015","unstructured":"Cherian JJ, Parvizi J, Bramlet D, Lee KH, Romness DW, Mont MA. Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-\u03b21 in patients with grade 3 chronic degenerative joint disease of the knee. Osteoarthritis Cartilage. 2015;23(12):2109.","journal-title":"Osteoarthritis Cartilage"},{"key":"1547_CR11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.blo.0000165845.21735.05","volume":"435","author":"AE Gross","year":"2005","unstructured":"Gross AE, Shasha N, Aubin P. Long-term follow up of the use of fresh osteochondral allografts for posttraumatic knee defects. Clin Orthop Relat Res. 2005;435:79.","journal-title":"Clin Orthop Relat Res"},{"key":"1547_CR12","first-page":"191","volume":"15","author":"WD Bugbee","year":"2002","unstructured":"Bugbee WD. Fresh osteochondral allografts. J Knee Surg. 2002;15:191.","journal-title":"J Knee Surg"},{"key":"1547_CR13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2106\/00004623-197456020-00007","volume":"56","author":"F Langer","year":"1974","unstructured":"Langer F, Gross AE. Immunogenicity of allograft articular cartilage. J Bone Joint Surg Am. 1974;56:297.","journal-title":"J Bone Joint Surg Am"},{"key":"1547_CR14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.csm.2008.10.007","volume":"28","author":"C Lattermann","year":"2009","unstructured":"Lattermann C, Romine SE. Osteochondral allografts: state of the art. Clin Sports Med. 2009;28:285.","journal-title":"Clin Sports Med"},{"key":"1547_CR15","first-page":"219","volume-title":"Tissue engineering in musculoskeletal clinical practice","author":"J Feder","year":"2004","unstructured":"Feder J, Adkisson HD, Kizer N, et al. The promise of chondral repair using neocartilage. In: Sandell LJ, Grodzinsky AJ, editors. Tissue engineering in musculoskeletal clinical practice. 1st ed. Rosemont: American Academy of Orthopedic Surgeons; 2004. p. 219.","edition":"1"},{"key":"1547_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-0030-1248155","volume":"18","author":"Y Lu","year":"2005","unstructured":"Lu Y, Adkisson HD, Bogdanske J, et al. In vivo transplantation of neonatal ovine neocartilage allografts: determining the effectiveness of tissue transglutaminase. J Knee Surg. 2005;18:31.","journal-title":"J Knee Surg"},{"key":"1547_CR17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.scr.2009.09.004","volume":"4","author":"HD Adkisson","year":"2010","unstructured":"Adkisson HD, Milliman C, Zhang X, et al. Immune evasion by neocartilage-derived chondrocytes: Implications for biologic repair of joint articular cartilage. Stem Cell Res. 2010;4:57.","journal-title":"Stem Cell Res"},{"key":"1547_CR18","first-page":"1015","volume":"21","author":"ML Rio del","year":"2008","unstructured":"del Rio ML, Buhler L, Gibbons C, et al. PD-1\/PD-L1, PD-1\/PD-L2, and other co-inhibitory signaling pathways in transplantation. Transpl Int. 2008;21:1015.","journal-title":"Transpl Int"},{"key":"1547_CR19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbrc.2005.08.232","volume":"338","author":"A Mellor","year":"2005","unstructured":"Mellor A. Indoleamine 2,3 dioxygenase and regulation of T cell immunity. Biochem Biophys Res Commun. 2005;338:20.","journal-title":"Biochem Biophys Res Commun"},{"key":"1547_CR20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/eji.200535602","volume":"36","author":"G Wingender","year":"2006","unstructured":"Wingender G, Garbi N, Schumak B, et al. Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO. Eur J Immunol. 2006;36:12.","journal-title":"Eur J Immunol"},{"key":"1547_CR21","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri1457","volume":"4","author":"AL Mellor","year":"2004","unstructured":"Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol. 2004;4:762.","journal-title":"Nat Rev Immunol"},{"key":"1547_CR22","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3899\/jrheum.100971","volume":"38","author":"SC Vlad","year":"2011","unstructured":"Vlad SC, Neogi T, Aliabadi P, et al. No association between markers of inflammation and osteoarthritis of the hands and knees. J Rheumatol. 2011;38:1665.","journal-title":"J Rheumatol"},{"key":"1547_CR23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/art.22369","volume":"56","author":"LI Sakkas","year":"2007","unstructured":"Sakkas LI, Platsoucas CD. The role of T cells in the pathogenesis of osteoarthritis. Arthritis Rheum. 2007;56:409.","journal-title":"Arthritis Rheum"},{"key":"1547_CR24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/joca.1998.0224","volume":"7","author":"H Nakamura","year":"1999","unstructured":"Nakamura H, Yoshino S, Kato T, et al. T-cell mediated inflammatory pathway in osteoarthritis. Osteoarthritis Cartilage. 1999;7:401.","journal-title":"Osteoarthritis Cartilage"},{"key":"1547_CR25","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.joca.2011.02.014","volume":"19","author":"PC Shen","year":"2011","unstructured":"Shen PC, Wu CL, Jou IM, et al. T helper cells promote disease progression of osteoarthritis by inducing macrophage inflammatory protein-1\u03b3. Osteoarthritis Cartilage. 2011;19:728.","journal-title":"Osteoarthritis Cartilage"},{"key":"1547_CR26","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1002\/eji.200324270","volume":"33","author":"N Rodig","year":"2003","unstructured":"Rodig N, Ryan T, Allen JA, et al. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol. 2003;33:3117.","journal-title":"Eur J Immunol"},{"key":"1547_CR27","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.4049\/jimmunol.169.10.5538","volume":"169","author":"T Yamazaki","year":"2002","unstructured":"Yamazaki T, Akiba H, Iwai H, et al. Expression of programmed death 1 ligands by murine T cells and APC. J Immunol. 2002;169:5538.","journal-title":"J Immunol"},{"key":"1547_CR28","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1053\/j.gastro.2004.02.004","volume":"126","author":"A Nakazawa","year":"2004","unstructured":"Nakazawa A, Dotan I, Brimnes J, et al. The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells. Gastroenterology. 2004;126:1347.","journal-title":"Gastroenterology"},{"key":"1547_CR29","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1073\/pnas.0931259100","volume":"100","author":"P Loke","year":"2003","unstructured":"Loke P, Allison JP. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc Natl Acad Sci U S A. 2003;100:5336.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1547_CR30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","volume":"2","author":"Y Latchman","year":"2001","unstructured":"Latchman Y, Wood CR, Chernova T, et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol. 2001;2:261.","journal-title":"Nat Immunol"},{"key":"1547_CR31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.193.7.839","volume":"193","author":"SY Tseng","year":"2001","unstructured":"Tseng SY, Otsuji M, Gorski K, et al. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med. 2001;193:839.","journal-title":"J Exp Med"},{"key":"1547_CR32","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","volume":"281","author":"DH Munn","year":"1998","unstructured":"Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 1998;281:1191.","journal-title":"Science"},{"key":"1547_CR33","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.4049\/jimmunol.164.7.3596","volume":"164","author":"P Hwu","year":"2000","unstructured":"Hwu P, Du MX, Lapointe R, et al. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol. 2000;164:3596.","journal-title":"J Immunol"},{"key":"1547_CR34","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","volume":"103","author":"R Meisel","year":"2004","unstructured":"Meisel R, Zibert A, Laryea M, et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood. 2004;103:4619.","journal-title":"Blood"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-017-1547-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T20:29:46Z","timestamp":1569356986000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-017-1547-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1547"],"URL":"https:\/\/doi.org\/10.1186\/s12891-017-1547-8","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,18]]},"article-number":"199"}}